common.study.topics.clinical

Golimumab for Adherence in Rheumatoid Arthritis

common.study.values.description

Golimumab for Adherence in Rheumatoid Arthritis

The purpose of this study is to determine if non-adherence to Rheumatoid Arthritis (RA) drugs in participants treated with biologic disease modifying anti-rheumatic drugs (DMARDs) is associated with a greater incidence of disease in clinical practice.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Recruiting patients only common.study.methods.is-healthy-yes

Biological - Golimumab

Participants will receive golimumab as a part of clinical practice.

participant.views.study.view.additional

participant.views.study.view.scientific-title

Golimumab for Adherence in Rheumatoid Arthritis

common.study.values.clinical-trial-id

NCT03729349

participant.views.study.view.id

e1wYjb